Effect of Adding Losartan to Bevacizumab for Treating Diabetic Macular Edema

Table 1

Comparison of clinical and laboratory data of the case and control groups.

Variable	Case group (n=33)	Control group	value
Stage of diabetic retinopathy			0.62
Moderate NPDR	11 (33.33%)	6 (21.5%)
Severe NPDR	22 (66.7%)	22 (78.5%)
Period of time	9.12 ± 4.26	11.15 ± 4.36	0.11
HbA1c (mg/dl)	208.1 ± 89.6	172.5 ± 65.4	0.08
FBS (mg/dl)	8.51 ± 1.66	8.11 ± 1.45	0.48

Chi-square test. T-test.